About Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology
During the past decade, Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 13 clinical trials were completed, i.e. on
average, 48.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology"
#1 collaborator was "Siriraj Hospital" with 2 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology
According to Clinical.Site data, the most researched conditions in "Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology" are
"Non-Small Cell Lung Cancer" (5 trials), "Breast Cancer" (4 trials), "Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology
Most popular intervention types in "Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology" are "Drug" (34 trials), "Procedure" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (15 trials), "Docetaxel" (9 trials), "Cisplatin" (6 trials), "Paclitaxel" (6 trials) and "Placebo" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology
The vast majority of trials in "Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology" are
34 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology
Currently, there are NaN active trials in "Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology".
undefined are not yet recruiting,
8 are recruiting,
10 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Faculty of Med. Siriraj Hosp.; Med.-Div. of Med. Oncology, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 27 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".